報價延遲最少15分鐘:2025/06/04 03:40 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
4.77 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-4.61/-0.76
|
|
企業價值
4.46M
|
| 資產負債 |
|
每股賬面淨值
2.05
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
0
|
|
每股收益
0.06
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/06/04 03:40 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes. |